IQVIA Holdings Inc. (IQV) News
Track canonical SquawkNews coverage tagged to IQV, IQVIA Holdings Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 14 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
IQVIA Partners With Medera
IQVIA partners with Medera for cardiac gene therapy
EQUITY | Aug 04, 2026, 08:18 PM UTC
H
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Tuesday. Shares of Sherwin-Williams Co (NYSE: SHW ) rose sharply after the company reported better-than-expected second-quarter financial resu
EARNINGS | Jul 28, 2026, 02:05 PM UTC
L
IQV +11% after Co forecasts 2026 revenue, profit above estimates
IQV +11% after Co forecasts 2026 revenue, profit above estimates
EQUITY | Jul 28, 2026, 01:32 PM UTC
H
IQV shares +10% premarket after results and guidance as raises FY2026 adj EPS forecast to $12.80-$13.00 from prior forecast of $12.65-$12.95
IQV shares +10% premarket after results and guidance as raises FY2026 adj EPS forecast to $12.80-$13.00 from prior forecast of $12.65-$12.95as midpoint tops ests $12.90; posted Q2 EPS and rev beat $4.37B vs. est. $4.3B -
EARNINGS | Jul 28, 2026, 12:48 PM UTC
H
Iqvia sees FY26 adjusted EPS $12.80-$13.00, consensus $12.80
Iqvia sees FY26 adjusted EPS $12.80-$13.00, consensus $12.80
EARNINGS | Jul 28, 2026, 11:12 AM UTC
H
Iqvia reports Q2 EPS $3.15, consensus $3.03
Reports Q2 revenue...
EARNINGS | Jul 28, 2026, 11:11 AM UTC
H
IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B
IQVIA Holdings (NYSE: IQV ) raises FY2026 Adj EPS guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 analyst estimate. Raises FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.275 billion-$17.475 billi
EARNINGS | Jul 28, 2026, 11:01 AM UTC
H
IQV IQVIA RESULTS: Q2, Q2 REV $4.368B vs. EST $4.301B, Q2 ADJ EPS $3.15 vs. EST $3.03, Q2 EPS $1.53, IQVIA Earnings Notes:, Outlook FY ADJ E
IQV IQVIA RESULTS: Q2, Q2 REV $4.368B vs. EST $4.301B, Q2 ADJ EPS $3.15 vs. EST $3.03, Q2 EPS $1.53, IQVIA Earnings Notes:, Outlook FY ADJ EPS $12.8-13 vs. EST $12.8, Outlook FY REV $17,275-17.475B vs. EST $17.286B
EARNINGS | Jul 28, 2026, 11:01 AM UTC
L
Implied EPS movers for tomorrow AM: KO +/-2.8%, GLW +/-10.6%, BA +/-4.7%, SHW +/-6.1%, SPGI +/-4.5%, HLT +/-3.6%, PCAR +/-6.5%, RCL +/-7.3%,
Implied EPS movers for tomorrow AM: KO +/-2.8%, GLW +/-10.6%, BA +/-4.7%, SHW +/-6.1%, SPGI +/-4.5%, HLT +/-3.6%, PCAR +/-6.5%, RCL +/-7.3%, UPS +/-5.6%, AMT +/-5.9%, ITW +/-5.3%, CARR +/-5.5%, ECL +/-6.0%, CNC +/-8.1%,
EQUITY | Jul 27, 2026, 05:42 PM UTC
L
Largest discount to VWAP QS (-6.31%) ACI (-5.23%) MEDP (-4.53%) MOH (-4.13%) RGEN (-3.89%) LITE (-3.46%) IQV (-3.41%) AUR (-3.37%) CMCSA (-3
Largest discount to VWAP QS (-6.31%) ACI (-5.23%) MEDP (-4.53%) MOH (-4.13%) RGEN (-3.89%) LITE (-3.46%) IQV (-3.41%) AUR (-3.37%) CMCSA (-3.3%) HUBS (-3.25%) (Russell 1000 names)
EQUITY | Jul 23, 2026, 03:42 PM UTC
H
Iqvia named short-term buy idea at Deutsche Bank
Deutsche Bank placed a "Catalyst call: Buy" on shares of Iqvia as a short-term investment idea. Iqvia has traded down 10% year-to-date and has underperformed peers despite 2026 guidance that the firm calls "in line-to-be
EARNINGS | Jul 09, 2026, 12:33 PM UTC
L
Iqvia price target raised to $240 from $210 at HSBC
HSBC analyst Sidharth Sahoo raised the firm's price target on Iqvia to $240 from $210 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's rel
EQUITY | Jul 06, 2026, 02:23 PM UTC
L
IQVIA shares are trading higher after Baird maintained its Outperform rating on the stock and raised its price target from $230 to $249.
IQVIA shares are trading higher after Baird maintained its Outperform rating on the stock and raised its price target from $230 to $249.
EQUITY | Jul 01, 2026, 02:18 PM UTC
L
Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249
Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE: IQV ) with a Outperform and raises the price target from $230 to $249.
EQUITY | Jul 01, 2026, 11:02 AM UTC